RIA therapy is crucial for treating thyroid disorders, specifically thyroid cancer. This study aims to evaluate the efficacy of 30 mCi and 50 mCi RIA therapy doses in low-risk papillary thyroid carcinoma patients post-thyroidectomy, based on their thyroglobulin levels. In order to achieve this goal, we have carefully analyzed and evaluated the thyroglobulin levels before and after radioiodine treatment while also examining the values from different viewpoints. In our thorough analysis, we found that about 90% of study participants experienced positive outcomes, indicating a high success rate....